Genencor International, Inc.'s Fourth Quarter and Year-End Earnings Conference Call on the Web Has Been Canceled

Genencor International, Inc.'s Fourth Quarter and Year-End
Earnings Conference Call on the Web Has Been Canceled 


PALO ALTO, Calif., Feb. 8  /PRNewswire-FirstCall/ -- Due to Genencor
International, Inc.'s (NASDAQ:GCOR) recent acquisition announcement, the fourth
quarter and year-end earnings call, scheduled for February 10, 2005 at 5:00
p.m., EST, with Jean-Jacques Bienaime, Chairman, Chief Executive Officer and
President and Raymond J. Land, Senior Vice President and Chief Financial
Officer has been canceled.

About Genencor

Genencor International, Inc. (http://www.genencor.com/) is a diversified
biotechnology company that develops and delivers innovative products and
services into the health care, agri-processing, industrial and consumer
markets. Using an integrated set of technology platforms, Genencor's products
deliver innovative and sustainable solutions to improve the quality of everyday
life.

Genencor traces its history to 1982 and has grown to become a leading
biotechnology company, with over $380 million in year 2003 annual revenues.
Genencor has principal offices in Palo Alto, California; Rochester, New York;
and Leiden, the Netherlands.

Genencor's fourth quarter and year-end earnings release will be issued on
February 10, 2005 at 4:00 p.m. EST and will be made available in the Press
Center section of the company's website, http://www.genencor.com/ 

DATASOURCE: Genencor International, Inc.



CONTACT:  Ruey-Li Hwang of Genencor International, Inc., [phone]



Web site:  http://www.genencor.com/ 

Copyright